# A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A

> **NCT05707351** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 37 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **BIOLOGICAL:** Adynovate

## Key facts

- **NCT ID:** NCT05707351
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-27
- **Primary completion:** 2024-09-05
- **Final completion:** 2024-09-05
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05707351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05707351, "A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05707351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*